FAKTOR-ZERTIFIKAT - BIOGEN IDEC | Market Closed - Börse Stuttgart 01:14:54 23/05/2024 am IST | ||
| 6.47 EUR | +17.42% |
|
| Current month | -35.04% | ||
| 1 month | -68.76% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 22/24/22 | 6.47 | +17.42% |
| 21/24/21 | 5.51 | -1.08% |
| 20/24/20 | 5.57 | -2.45% |
| 17/24/17 | 5.71 | +1.06% |
| 16/24/16 | 5.65 | +6.81% |
Delayed Quote Börse Stuttgart
Last update May 23, 2024 at 01:14 am IST
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | J.P. Morgan |
| WKN | JK4G0K |
| ISIN | DE000JK4G0K3 |
| Date issued | 22/03/2024 |
| Strike | 265.6 $ |
| Maturity | Unlimited |
| Parity | 6.04 : 1 |
| Emission price | 10.07 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 24.22 € |
|---|---|
| Lowest since issue | 4.95 € |
| Spread | 0.3 € |
| Spread % | 4.48% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
33
Last Close Price
225.2
USD
Average target price
287.3
USD
Spread / Average Target
+27.57%
- Stock Market
- Certificates
- Certificat
